HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Case report: Rapid improvement of crossed cerebellar diaschisis after intravascular laser irradiation of blood in a case of stroke.

AbstractRATIONALE:
Crossed cerebellar diaschisis (CCD) is a poor prognostic factor after stroke because without immediate cerebral reperfusion no further improvements in the patient's condition can be achieved. We investigated the clinical effects of intravascular laser irradiation therapy (ILIB) on CCD and evaluated the therapeutic effect in the sub-acute post-stroke stage.
PATIENT CONCERNS:
The 77-year-old male with cerebral infarction in the territory of the right anterior cerebral artery only underwent conservative treatment including hydration and aspirin in the acute post-stroke stage.
DIAGNOSIS:
He was diagnosed as stroke based on the clinical presentations and imaging findings.
INTERVENTION:
Once the patient was in stable condition, he underwent a daily hour-long ILIB (He-Ne laser) for ten consecutive days during the sub-acute post-stroke stage.
OUTCOMES:
We used single-photon emission computed tomography (SPECT) before and after intravascular laser irradiation to detect changes in cerebral and cerebellar perfusion. Then, we compared the two images. CCD was detected using the first SPECT. After intervention by ILIB, the second SPECT showed greater perfusion in the affected cerebellar hemisphere.
LESSONS:
We found that ILIB helped eliminate CCD, which was previously shown to be an untreatable condition using any intervention during the sub-acute post-stroke stage. Stroke patients could therefore greatly benefit from ILIB.
AuthorsWan-Hua Yang, Shiou-Ping Lin, Shin-Tsu Chang
JournalMedicine (Medicine (Baltimore)) Vol. 96 Issue 2 Pg. e5646 (Jan 2017) ISSN: 1536-5964 [Electronic] United States
PMID28079797 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Cerebellar Diseases (etiology, therapy)
  • Endovascular Procedures
  • Humans
  • Infarction, Anterior Cerebral Artery (complications)
  • Low-Level Light Therapy
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: